The Centers for Medicare & Medicaid Services late today issued a proposed rule to update skilled nursing facility payment rates for fiscal year 2022. The rule would update payments by a net 1.3% relative to FY 2021 ($444 million), which includes a 2.3% market basket, a 0.2 percentage point productivity reduction and a forecast error adjustment to account for prior overpayment. CMS also would update the diagnosis code mappings used in the case-mix system implemented in FY 2021, and rebase and revise the SNF market basket. 

CMS also proposes to adopt two new quality measures beginning in FY 2023. One would assess the rate of COVID-19 vaccination among health care personnel, and the other would calculate healthcare-associated infections acquired in SNFs based on claims for subsequent hospitalizations. For the SNF Value-based Purchasing program, CMS proposes to suppress data for the single measure used in that program due to the impact of the COVID-19 pandemic, and instead will issue a uniform 1.2% payback percentage to participating SNFs with sufficient case volume rather than determining payment adjustments based on performance.

Comments on this rule are due to CMS by June 7.
 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned…
Headline
All 50 states have applied for the Rural Health Transformation Program, the Centers for Medicare & Medicaid Services announced Nov. 5. The program will…
Headline
Bill Gassen, Sanford Health president and CEO and AHA chair-elect designate, and Deb Koski, Sanford Health chief philanthropy officer, discuss how a strong…
Headline
The AHA commented Nov. 3 on the Centers for Medicare & Medicaid Services’ calendar year 2026 final rule for the physician fee schedule. The rule, released…
Headline
The Centers for Medicare & Medicaid Services Oct. 31 released its calendar year 2026 final rule for the physician fee schedule. As required by law,…
Headline
The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model…